06 Aug 2020 --- Throughout the global COVID-19 pandemic, NutritionInsight is dedicated to bringing its readers all the latest and most relevant industry updates. Visit this daily news feed for the... Read More

20 Jul 2020 --- Lallemand Health Solutions will commercialize Proge Farm’s L. plantarum P17630 (Proge P17630) probiotic strain, which can aid in maintaining an equilibrium of a normal vaginal... Read More

03 Jul 2020 --- This week in nutrition news, Evolva set itself up to strengthen its resveratrol products’ position in the nutrition sector with an agreement to issue and subscribe convertible... Read More

30 Jun 2020 --- Direct-to-consumer custom probiotics start-up Sun Genomics has raised US$8.65 million in its Series A funding. The round was led by Pangaea Ventures with additional investments from... Read More

30 Jun 2020 --- The nutrition industry is fighting back against allegations that probiotics lack industry regulation and sport insufficient scientific consensus over their health benefits. The... Read More

24 Jun 2020 --- The microbiome is in the spotlight as consumers seek to understand the inner workings of their bodies. Adam Baker, Director of Human Science and Health Innovation at Chr. Hansen, details how microbiome research has been making strides in recent years, with responsibility falling to industry to ensure that various strains are properly investigated and accurately marketed.  

31 May 2013 --- Chr. Hansen has launched a new probiotic product which has the potential to improve the gut and immune health of infants and young children: probiotic drops containing Chr. Hansen’s bacteria strain BB-12 and sunflower oil.

12 Jan 2012 --- Marie Brenoe of Chr. Hansen on Taking Probiotics to Juice Applications.

01 Feb 2016 --- Danish-headquartered Chr. Hansen has reported a strong start to the 2015/2016 financial year. An interview with Sten Estrup, VP at Chr. Hansen who talks about how new partnerships are indicative of how the company is investing in the future.

30 Nov 2014 --- Key suppliers offer their thoughts on the key dairy trends. How can manufacturers benefit from the mainstreaming of the sports nutrition sector? How can the boom in protein and the needs of the aging global population be addressed?

01 Mar 2013 --- Knud Vindfeldt: “Chr. Hansen has a clear strategy to obtain EU approved health claims for our core probiotic strains. While the EFSA demands are high and timelines have been challenging, this does not change our strategy. To protect our customers and consumers from conflicting messages, we will only submit our applications for health claims when we are confident we have sufficient data to meet the EFSA requirements.”

15 Jun 2020 --- In this week’s episode of the NewsBite podcast, NutritionInsight reports on numerous acquisitions, including those from DSM, Chr. Hansen and Nestlé Health Science. Meanwhile, research is booming in spaces including respiratory infections and the microbiome. Read more:DSM snaps up Erber for US$1bn as it prioritizes acquisitionsNestlé Health Science’s HMOs slash respiratory tract infections in infants with cow’s milk protein allergyActiv’Inside in US$19m collaboration to fight cognitive decline in elderly

20 Apr 2020 --- NutritionInsight’s recurring podcast returns to provide the most important industry-related news and information from the past few days. This week, research related to COVID-19 extended into eicosapentaenoic acid free fatty acid, sweet wormwood extract and probiotics, while nutrition companies continue to navigate supply chain disruptions. Read more:Moves for immunity: Chr. Hansen launches online probiotic education platformFatty acid and sweet wormwood on road to clinical trials for COVID-19AHPA reports supply chain disruptions to USDA amid mounting industry concerns

06 Nov 2018 --- Mauricio Graber took the helm as new Chr. Hansen CEO on June 1, 2018, having previously served as President of the Flavours Division of Givaudan. Chr. Hansen recently reported its Q4 and full financial earnings. The company announced that it had achieved the overall financial targets set at the beginning of the year and raised its ambitions 9-11 percent organic growth for next year. It is the company’s core business of Cultures & Enzymes, which represents 59 percent of their business that performed the strongest, with bioprotection and probiotics forming key pillars here. FoodIngredientsFirst spoke with Mauricio about the current business environment and new opportunities for microbes.

06 Nov 2017 --- Danish-headquartered ingredients supplier Chr. Hansen recently announced its annual results, with organic growth reported of 10 percent for 2016/2017. Food Cultures & Enzymes and Health & Nutrition both delivered strong growth, performing slightly above the long-term ambitions for these businesses, while Natural Colors grew in line with ambitions. The key focus for Chr. Hansen continues to be strong organic growth through innovation and the company notes that with good progress in many of its strategic initiatives, the building blocks for achieving its ambitious financial targets are in place.Soeren Westh Lonning, CFO at Chr. Hansen discusses the company’s strategy shortly after the results were announced.